EP300 and neoplasm: Immunostaining for total and AcH3 showed fewer AcH3-positive tumor cells with EP300-knockdown, and quantitation revealed that this reduction was significant in radiated, EP300-deficient tumors (Supplementary Fig. 7f, g).